Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ali Ataya

Pulmonary Vascular Med · UF

View

Dr. Naftali Kaminski

Interstitial Lung Disease · Yale College

View

Dr. Auston Stiefer

Interstitial Lung Disease · CU Anschutz Medical Campus

View

Dr. Justin Zhang

Critical Care · UCLA

View

Dr. Panagis Galiatsatos

Critical Care · Johns Hopkins

View

Dr. MeiLan Han

Asthma & COPD · UMHS

View

Dr. Kevin Chung

Critical Care · SeaStar Medical

View

Dr. Diego J. Maselli

Asthma & COPD · UTHSCSA

View

Dr. Amos E. Dodi

Critical Care · MMC

View

Dr. Imre Noth

Interstitial Lung Disease · University of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    AHDr. Anna Hemnes

    Dr. Anna Hemnes

    Pulmonology & Critical Care · Pulmonary Vascular Medicine
    Vanderbilt Health
    annahemnes

    Research

    Inflammation, obesity, and outcomes in pulmonary arterial hypertension: toward precision-driven care

    2026

    Via Am J Respir Crit Care Med

    Dec 3, 2025Journal Article

    Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.

    ​
    ​

    Written by 2 Roon authors & 15 others

    Via The American Heart Association Journals

    Research

    Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

    2026

    Via Drugs Real World Outcomes

    Feb 13, 2026Journal Article

    Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.

    ​
    ​

    Written by 2 Roon authors & 20 others

    Via The American Heart Association Journals

    Research

    Pulmonary artery size on computed tomography associates with mean pulmonary artery pressure and mortality

    2026

    Via Ann Am Thorac Soc

    Apr 2, 2026Journal Article

    Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.

    ​

    Written by 1 Roon author & 10 others

    Via The American Heart Association Journals

    Research

    Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD

    2026

    Via Thorax

    May 21, 2026Journal Article

    Right Heart Diastology, Where Are We Now?

    ​

    Written by 1 Roon author & 6 others

    Via The American Heart Association Journals

    Research

    Corrigendum to 'The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry'[J Heart Lung Transplant, 45 (2026) 125-136]

    2026

    Via J Heart Lung Transplant

    Research

    Lactobacillus Is Associated With Disease in Pulmonary Arterial Hypertension: A Prospective Cohort Study

    2026

    Via Compr Physiol

    Research

    Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension

    2026

    Via Eur Respir J

    Research

    Resolving Diagnostic Discordance in Group 2 Pulmonary Hypertension Through Staged Physiologic Testing: Insights From PVDOMICS

    2026

    Via medRxiv

    Research

    Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension

    2026

    Via bioRxiv

    May 18, 2026Journal Article

    Variation in SNX29 and Acute Vasodilator Response in Pulmonary Arterial Hypertension.

    ​

    Written by 1 Roon author & 34 others

    Via The American Heart Association Journals
    Jul 17, 2026Journal Article

    Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.

    ​

    Written by 1 Roon author & 27 others

    Via The American Heart Association Journals